Skip to main content
Log in

Antipsychotic use in children: quality-of-care concerns

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Office of Inspector General, US Department of Health and Human Services. SECOND-GENERATION ANTIPSYCHOTIC DRUG USE AMONG MEDICAID-ENROLLED CHILDREN: QUALITY-OF-CARE CONCERNS. Internet Document : Mar 2015. Available from: URL: http://oig.hhs.gov/oei/reports/oei-07-12-00320.pdf

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antipsychotic use in children: quality-of-care concerns. PharmacoEcon Outcomes News 726, 1 (2015). https://doi.org/10.1007/s40274-015-2049-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2049-2

Navigation